Family of abnormal antithrombin III. Clinical studies
Takahashi, K.; Sakuragawa, N.
Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 50: 137-145
1982
ISSN/ISBN: 0047-1860 PMID: 7131804 Document Number: 195875
Document emailed within 1 workday
Related Documents
Nagy, I.; Losonczy, H. 1982: Comparative studies on the determination of abnormal antithrombin IIi activity Folia Haematologica 109(1): 180-183Akai, Y.; Shiga, S.; Tohyama, K.; Shimatsu, A.; Ichiyama, S. 2000: Effect of heparin cofactor Ii on the antithrombin IIi activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women Rinsho Byori. Japanese Journal of Clinical Pathology 48(9): 867-871
Tripodi, A.; Krachmalnicoff, A.; Mannucci, P.M. 1986: Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding Thrombosis and Haemostasis 56(3): 349-352
Sakurabayashi, I.; Kawai, T.; Omizo, R.; Hattori, N.; Ishii, M. 1988: Fundamental studies, reference values, and clinical evaluation of abnormal prothrombin PIVKA-II assay using monoclonal antibody (E-1023) Rinsho Byori. Japanese Journal of Clinical Pathology 36(12): 1407-1412
Kamijo, K.; Kawasaki, K.; Sato, M.; Yachi, A. 1989: Clinical studies on the relation of abnormal growth hormone secretions to hepatic diabetes mellitus in patients with hepatocellular carcinoma Gan no Rinsho. Japan Journal of Cancer Clinics 35(7): 775-779
Kamijo, K.; Kawasaki, K.; Sato, M.; Yachi, A. 1989: Clinical studies on the relation of abnormal growth hormone secretions to hepatic diabetes mellitus in patients with hepatocellular carcinoma Gan no Rinsho. Japan Journal of Cancer Clinics 35(7): 775-779
Ikeuchi, T.; Ueno, M. 1993: Clinical studies on chronic prostatitis and prostatitis-like syndrome (6). Clinical evaluation for the chronic prostatitis-like syndrome patients with severe symptoms of voiding and abnormal uroflowmetric results Hinyokika Kiyo. Acta Urologica Japonica 39(4): 321-325
Jeong, H.; Kim, M.; Lee, J.; Hahn, S.H.; Park, S.; Yoo, O.J. 1997: A 5-nucleotide insertion in the antithrombin gene causing a quantitative antithrombin deficiency Thrombosis and Haemostasis 77(1): 212-213
Gerhards, H. 1987: Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency Tierarztliche Praxis 15(1): 47-55
Fujimaki, M.; Nagasawa, H. 1974: Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3 Nihon Rinsho. Japanese Journal of Clinical Medicine 32(5): 942-947
Nee, L.E.; Polinsky, R.J.; Ebert, M.H. 1982: Tourette syndrome: clinical and family studies Advances in Neurology 35: 291-295
Wu, Y.; Cao, J. 1996: Some thoughts on clinical family planning studies Zhonghua Yi Xue Za Zhi 76(5): 323-324
Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J. 2002: Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122
Fujii, K.; Takanashi, J.; Saito, Y.; Tamai, K.; Kondo, I.; Sugita, K.; Niimi, H. 1997: A family of dentatorubral-pallidoluysian atrophy: clinical and neuroradiologic studies No to Hattatsu 29(4): 298-302
Haussmann, U.; Fischer, J.; Eber, S.; Scherer, F.; Seger, R.; Gungor, T. 2006: Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy Haematologica 91(6): 795-800
Vinazzer, H.; Bergmann, H.; Blauhut, B. 1984: The clinical value of antithrombin IIi Wiener Medizinische Wochenschrift 134(12): 279-283
Shinyama, H.; Akira, T.; Uchida, T.; Hirahara, K.; Watanabe, M.; Kagitani, Y. 1996: Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia Journal of Cardiovascular Pharmacology 27(5): 702-711
Andreenko, G.V.; Poliantseva, L.R.; Podorol'skaia, L.V. 1980: Antithrombin IIi and its role in clinical pathology Terapevticheskii Arkhiv 52(2): 141-145
Mammen, E.F. 1995: Clinical relevance of antithrombin deficiencies Seminars in Hematology 32(4 Suppl 2: 2-6; Discussion 7
Niessen, R.W.; Lamping, R.J.; Jansen, P.M.; Prins, M.H.; Peters, M.; Taylor, F.B.; de Vijlder, J.J.; ten Cate, J.W.; Hack, C.E.; Sturk, A. 1997: Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons Thrombosis and Haemostasis 78(3): 1088-1092